Skip to main content
Clinical Trials/JPRN-UMIN000015356
JPRN-UMIN000015356
Completed
Phase 1

A PET (positron emission tomography) clinical research study using prostate specific membrane antigen (PSMA) targeted tracer, 89Zr-Df-IAB2M - A PET (positron emission tomography) clinical research study using prostate specific membrane antigen (PSMA) targeted tracer, 89Zr-Df-IAB2M

niversity of Tsukuba0 sites15 target enrollmentOctober 8, 2014

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Prostate cancer / Urothelial carcinoma / Renal cell carcinoma / Testicular cancer
Sponsor
niversity of Tsukuba
Enrollment
15
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 8, 2014
End Date
August 31, 2016
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Tsukuba

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) In a clinical trial, patients who need to receive the new treatment (2\) Patinets with severe pulmonary, renal, gastrointestinal, hematological or psychonurological disease (3\) Patients whose doctors determined as inadequate for the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Brentuximab Vedotin in combination with donor lymphocyte infusions for Hodgkin lymphoma relapsing or persisting after allogeneic stem cell transplantatio
ACTRN12619000581167Melbourne Health10
Completed
Not Applicable
Positron emission tomography (PET) guided therapy of diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) with or without high dose chemotherapy followed by autologous stem cell transplantation (HDC/ASCT)Diffuse large B-cell lymphoma
JPRN-UMIN000004420Japan Study Group for Cell Therapy and Transplantation68
Completed
Not Applicable
Clinical study using positron emission tomography(PET)brain tumor,epilepsy,multiple sclerosis, neuromyelitis,Duchenne musclar dystrophy,Alzheimer&#39s disease,Down Syndrome,Hydrocephalus
JPRN-UMIN000005626Center for Integrated Human Brain Science, Brain Research Institute, University of Niigata100
Completed
Not Applicable
The impact of Positron Emission Tomography (PET) imaging in staging potentially surgically resectable non-small cell lung cancers: a prospective, multicentre randomised clinical trialStage I, II, IIIA Non-small Cell Lung CancerCancerMalignant neoplasm of lung
ISRCTN67987497McMaster University (Canada)322
Not yet recruiting
Not Applicable
Positron Emission Tomography as a diagnostic tool in Unilateral Condylar Hyperplasia and comparison with bone scintigraphy, including SPECTTemporo-Mandibulaire Gewrichtgrowth of the temporo-mandibular jointUnilateral Condylar Hyperplasia
NL-OMON30174Vrije Universiteit Medisch Centrum6